Novavax recently announced that a single booster dose of its COVID-19 vaccine, NVX-CoV2373, elicited a 4.6-fold increase in functional antibody titers six months after an initial two-dose...
Merck recently announced that FDA accepted for review a new supplemental Biologics License Application seeking approval for its antibody, Keytruda, for patients with advanced endometrial...
The Department of Defense (DoD) recently awarded a $6 million technology and therapeutic development award to the University of Illinois (UIC) to test a COVID-19 drug candidate.
UIC will use the...
Bristol Myers Squibb recently announced its voluntarily withdrawal of the indication for Opdivo, its single-agent immunotherapy for patients with hepatocellular carcinoma (HCC), from the US...
The Justice Department announced that St. Jude Medical agreed to pay $27 million to resolve a healthcare fraud allegation that it violated the False Claims Act and sold defective heart...
Gavi recently signed an advance purchased agreement with Sinopharm and Sinovac for their respective COVID-19 vaccines.
The purchase agreements for Sinopharm’s “BBIBP-CorV” and...
Pfizer, AbbVie, and Biogen recently launched the world’s largest browsable resource linking rare protein-coding genetic variants to human health and disease.
The genetic exome sequence...
FDA recently reversed its broad approval for Biogen’s Alzheimer’s drug, Aduhelm, after being approved just last month, according to multiple news outlets.
The agency now recommends...
FDA recently approved Jazz Pharmaceutical’s Rylaze as a component of a chemotherapy regimen to treat the most common childhood cancer
Specifically, Rylaze was approved to treat lymphoblastic...
Moderna recently announced that its COVID-19 vaccine produced neutralizing titers against all coronavirus variants tested in a Phase 1 clinical trial.
Specifically, Moderna COVID-19 Vaccine...
FDA recently approved Boehringer Ingelheim Pharmaceuticals Pradaxa, the first oral blood thinning medication for children three months to less than 12 years old with venous thromboembolism.
Pradaxa...
Biogen’s Alzheimer’s drug, Aduhelm, is expected to increase prescription drug spending and the national health expenditure more than $73 billion by 2028, according to a new Altarum...
Gilead recently announced that its COVID-19 treatment, remdesivir, lowered the risk for mortality compared with matched controls in patients hospitalized with the virus.
The three real-world data...
CRISPR Therapeutics and Capsida Biotherapeutics recently entered into a collaboration to develop, manufacture, and commercialize gene therapies.
The companies will leverage adeno-associated...
Thermo Fisher Scientific recently launched the Ion AmpliSeq SARS-CoV-2 Insight Research Assay to improve surveillance and identification of new and known COVID-19 variants from samples with lower viral...
New data showed that Pfizer’s tofacitinib elicited a lower cumulative incidence of death or respiratory failure through day 28 compared to placebo in COVID-19 patients hospitalized with...
FDA recently approved Novo Nordisk’s Wegovy obesity drug for chronic weight management in overweight adults with at least one weigh-related condition, including high blood pressure, type 2...
Pfizer and BioNTech will provide the US government with 500 million doses of their COVID-19 vaccine; the allotment includes 200 million doses in 2021 and 300 million doses in 2022 at a not-for-profit...
Abbott and Walgreens recently launched a pilot program to increase access to rapid COVID-19 testing for Pennsylvania Electronic Benefit Transfer (EBT) cardholders in the city of Philadelphia.
Under...
Merck and Sanofi recently announced that their six-in-one combination pediatric vaccine is now available throughout the US.
Vaxelis is the first and only hexavalent combination vaccine available...
